Ishara Investments LP
41 holdingsFiling period: 2026-06-30Current AUM: $120.8Mestimated from latest prices
| # | Ticker | Company | Shares | Reported Value | Current Value | % Portfolio | Change | Date |
|---|---|---|---|---|---|---|---|---|
| 1 | ACAD | Acadia Pharmaceuticals Inc | 410.0K | $10.4M | $8.7M | 7.21% | +287.0K | 2026-06-30 |
| 2 | XERS | Xeris Biopharma Holdings Inc | 1.23M | $9.7M | $18.7M | 15.48% | +205.0K | 2026-06-30 |
| 3 | BMRN | Biomarin Pharmaceutical Inc | 143.5K | $8.2M | $8.0M | 6.66% | +61.5K | 2026-06-30 |
| 4 | PRAX | Praxis Precision Medicines I | 22.6K | $7.5M | $6.3M | 5.18% | -20,500 | 2026-06-30 |
| 5 | RARE | Ultragenyx Pharmaceutical in | 205.0K | $6.8M | $3.2M | 2.62% | +30.8K | 2026-06-30 |
| 6 | AGIO | Agios Pharmaceuticals Inc | 164.0K | $6.1M | $4.8M | 3.99% | -- | 2026-06-30 |
| 7 | INSM | Insmed Inc | 51.3K | $5.5M | $5.9M | 4.85% | -- | 2026-06-30 |
| 8 | CRNX | Crinetics Pharmaceuticals in | 143.5K | $5.4M | $5.4M | 4.45% | -- | 2026-06-30 |
| 9 | ZNTL | Zentalis Pharmaceuticals Inc | 1.02M | $5.0M | $1.8M | 1.46% | -205,000 | 2026-06-30 |
| 10 | PCVX | Vaxcyte Inc | 82.0K | $4.8M | $5.2M | 4.34% | +24.6K | 2026-06-30 |
| 11 | ANNX | Annexon Inc | 820.0K | $4.7M | $3.4M | 2.85% | +645.8K | 2026-06-30 |
| 12 | TVTX | Travere Therapeutics Inc | 82.0K | $4.7M | $4.1M | 3.37% | -28,700 | 2026-06-30 |
| 13 | TNXP | Tonix Pharmaceuticals Hldg C | 338.3K | $4.3M | $1.6M | 1.33% | -- | 2026-06-30 |
| 14 | BBIO | Bridgebio Pharma Inc | 57.4K | $4.3M | $4.3M | 3.53% | -- | 2026-06-30 |
| 15 | AXSM | Axsome Therapeutics Inc. | 16.4K | $4.0M | $2.2M | 1.80% | -24,600 | 2026-06-30 |
| 16 | CTNM | Contineum Therapeutics Inc | 205.0K | $3.4M | $2.0M | 1.62% | +63.0K | 2026-06-30 |
| 17 | LXRX | Lexicon Pharmaceuticals Inc | 1.27M | $3.0M | $2.3M | 1.87% | +369.0K | 2026-06-30 |
| 18 | KURA | Kura Oncology Inc | 276.8K | $3.0M | $2.0M | 1.67% | -- | 2026-06-30 |
| 19 | DBVT | Dbv Technologies S A | 184.5K | $3.0M | $1.9M | 1.60% | +82.0K | 2026-06-30 |
| 20 | GMAB | Genmab A/S | 102.5K | $2.8M | $5.5M | 4.55% | +20.5K | 2026-06-30 |
| 21 | CYTK | Cytokinetics Inc | 32.8K | $2.8M | $1.8M | 1.46% | -- | 2026-06-30 |
| 22 | MLYS | Mineralys Therapeutics Inc | 102.5K | $2.8M | $1.6M | 1.30% | +20.5K | 2026-06-30 |
| 23 | SLN | Silence Therapeutics PLC | 55.4K | $2.4M | $4.4M | 3.62% | -85,150 | 2026-06-30 |
| 24 | NUVB | Nuvation Bio Inc | 369.0K | $2.1M | $1.5M | 1.27% | -- | 2026-06-30 |
| 25 | — | Wave Life Sciences Ltd | 328.0K | $1.9M | $1.9M | 1.58% | -- | 2026-06-30 |
← Scroll →
Page 1 of 2